DK1351950T3 - Isoquinolinylaroylpyrrolforbindelser ti behandling af lidelser i centralnervesystemet - Google Patents

Isoquinolinylaroylpyrrolforbindelser ti behandling af lidelser i centralnervesystemet

Info

Publication number
DK1351950T3
DK1351950T3 DK01989198T DK01989198T DK1351950T3 DK 1351950 T3 DK1351950 T3 DK 1351950T3 DK 01989198 T DK01989198 T DK 01989198T DK 01989198 T DK01989198 T DK 01989198T DK 1351950 T3 DK1351950 T3 DK 1351950T3
Authority
DK
Denmark
Prior art keywords
treatment
nervous system
central nervous
system disorders
isoquinolinylaroylpyrrole
Prior art date
Application number
DK01989198T
Other languages
English (en)
Inventor
John R Carson
Philip M Pitis
Original Assignee
Ortho Mcneil Pharm Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ortho Mcneil Pharm Inc filed Critical Ortho Mcneil Pharm Inc
Application granted granted Critical
Publication of DK1351950T3 publication Critical patent/DK1351950T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/06—Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P21/00—Drugs for disorders of the muscular or neuromuscular system
    • A61P21/02—Muscle relaxants, e.g. for tetanus or cramps
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
DK01989198T 2000-12-20 2001-12-11 Isoquinolinylaroylpyrrolforbindelser ti behandling af lidelser i centralnervesystemet DK1351950T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US25686500P 2000-12-20 2000-12-20
PCT/US2001/047639 WO2002057253A2 (en) 2000-12-20 2001-12-11 Isoindolyl and isoquinolinyl aroyl pyrrole compounds for the treatment of central nervous system disorders

Publications (1)

Publication Number Publication Date
DK1351950T3 true DK1351950T3 (da) 2007-12-03

Family

ID=22973908

Family Applications (1)

Application Number Title Priority Date Filing Date
DK01989198T DK1351950T3 (da) 2000-12-20 2001-12-11 Isoquinolinylaroylpyrrolforbindelser ti behandling af lidelser i centralnervesystemet

Country Status (12)

Country Link
US (1) US6492387B2 (da)
EP (1) EP1351950B1 (da)
JP (1) JP2004517893A (da)
AT (1) ATE369354T1 (da)
AU (1) AU2002243310A1 (da)
CA (1) CA2432776A1 (da)
CY (1) CY1106922T1 (da)
DE (1) DE60129846T2 (da)
DK (1) DK1351950T3 (da)
ES (1) ES2291373T3 (da)
PT (1) PT1351950E (da)
WO (1) WO2002057253A2 (da)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0109957D0 (en) * 2001-04-24 2001-06-13 Martin Sanders T A Vensha Inno Binding system
DE10261131A1 (de) * 2002-12-20 2004-07-01 Grünenthal GmbH Substituierte 5-Aminomethyl-1H-pyrrol-2-carbonsäureamide

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5332736A (en) * 1993-11-01 1994-07-26 Ortho Pharmaceutical Corporation Anti-convulsant aroyl aminoacylpyrroles
US5760007A (en) 1997-07-16 1998-06-02 Ortho Pharmaceutical Corporation Anticonvulsant derivatives useful in treating neuropathic pain
DK1154996T3 (da) * 1999-02-18 2004-02-16 Ortho Mcneil Pharm Inc Aminoacylaroylpyrroler til behandling af neuropatisk smerte
WO2002002521A2 (en) 2000-06-30 2002-01-10 Ortho-Mcneil Pharmaceutical, Inc. Aroyl aminoacyl pyrrole compounds and their pharmaceutical use

Also Published As

Publication number Publication date
WO2002057253A3 (en) 2002-10-24
US6492387B2 (en) 2002-12-10
US20020128286A1 (en) 2002-09-12
ATE369354T1 (de) 2007-08-15
ES2291373T3 (es) 2008-03-01
PT1351950E (pt) 2007-10-02
JP2004517893A (ja) 2004-06-17
EP1351950A2 (en) 2003-10-15
CY1106922T1 (el) 2012-09-26
CA2432776A1 (en) 2002-07-25
WO2002057253A2 (en) 2002-07-25
DE60129846D1 (de) 2007-09-20
AU2002243310A1 (en) 2002-07-30
DE60129846T2 (de) 2008-05-08
EP1351950B1 (en) 2007-08-08

Similar Documents

Publication Publication Date Title
ATE376832T1 (de) Verzögert freisetzende formulierungen von oxymorphon
ES2168650T3 (es) Compuestos y metodos moduladores de receptores de androgenos.
DK1371647T3 (da) Pyrazolopyrimidinon-cGMP PDE5-inhibitorer til behandling af sexualforstyrrelse
AU2002220715A1 (en) Indolsulfonyl compounds useful in the treatment of cns disorders
MA28909B1 (fr) Quinazolines utiles en tant que modulateurs de canaux ioniques
NO20043085L (no) Fremgangsmater og sammensetninger for behandling av forstyrrelser i sentralnervesystemet
MY124786A (en) Bis-arylsulfones
ATE527251T1 (de) Bicyclische derivate als modulatoren von ionenkanälen
DK1578740T3 (da) 1,2,4-triaminobenzenderivater, der er egnede til behandling af lidelser i centralnervesystemet
IL155589A0 (en) Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders
DK1001761T3 (da) Anvendelse af cholinesteraseinhibitorer til behandling af opmærksomhedsunderskudslidelser
NO20025405D0 (no) Modulatorer for TNF-alfa-signalisering
DE69835288D1 (de) Kombinationstherapie zur modulation der humanen sexualreaktion
DK0946157T3 (da) Topisk anvendelse af kappa-opioid agonister til behandling af øjensmerte
SE9801494D0 (sv) Novel use
UY26426A1 (es) Nuevos compuestos
DK1109814T3 (da) 5-Heterocyclylpyrazolo[4,3-d]pyrimidin-7-oner til behandling af mandlig erektil dysfunktion
ATE255094T1 (de) Piperazinderivate zur behandlung der niedrigen harnwege
CY1106922T1 (el) Ενωσεις ισοκινολινυλ αροϋλ πυρρολης για την αγωγη των διαταραχων κεντρικου νευρικου συστηματος
DE60133385D1 (de) (+)-alpha-(2,3-dimethoxyphenyl)-1-(2-(4-fluorophenyl)ethyl)-4-piperidinemethanol oder prodrug davon zur behandlung von demenzsymptomen oder kognitiven störungen
DK1642576T3 (da) Anvendelse af pyrrolderivater til at bekæmpe angst
EE200200670A (et) S-metüüldihüdroziprasidoon psühhiaatriliste ja silmahaiguste raviks
WO2004016604A3 (en) Azabicyclic compounds are central nervous system active agents
NO20026246D0 (no) 2-aminoalkyl-tieno[2,3-d]pyrimidiner
EA200200750A1 (ru) Новое терапевтическое применение еноксапарина